中年人的医疗保健支出和利用率在并发症,功能限制和种族/民族的交叉点
Mohammad Usama Toseef1,2, Shanmin Sultana3, Preethy Samuel3
1Corewell Health Research Institute, Royal Oak, Michigan, United States.
Innovation in aging
|February 20, 2026
概括
患有复杂慢性疾病的中年成人面临更高的医疗费用. 种族/种族和功能限制显著影响医疗服务使用和支出模式,突出了针对性干预的必要性.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 慢性疾病管理 慢性疾病管理
- 健康差异 在健康上的差异
背景情况:
- 中年是健康转型的关键生命阶段,慢性疾病和功能限制正在出现.
- 种族/种族等社会决定因素会加剧并发症和功能限制影响.
- 了解这些因素对于中年成年人的健康轨迹至关重要.
研究的目的:
- 检查伴随性疾病,功能限制和种族/种族如何影响中年成年人医疗服务使用和支出.
- 根据这些因素,确定医疗保健利用和支出方面的差异.
- 为弱势群体提供有针对性的医疗保健策略.
主要方法:
- 从医疗支出小组调查 (2008-2022,不包括2020年) 收集了50-64岁的成年人的综合横截面数据.
- 隐性类分析 (LCA) 用于识别并发症表型.
- 通用线性回归用于评估与医疗服务结果的关联,控制功能限制和种族/种族.
主要成果:
- 确定了三个并发症类别:低患病率 (63.4%),高血压/关节炎/关节疼痛 (29.3%),以及复杂的心血管 (C-CVD,7.3%).
- 心血管疾病患者的医疗保健支出和使用率较高,包括急诊室 (ED) 和住院住院,尽管更多的办公室访问 (OBV).
- 非西班牙裔黑人 (NHB) 和西班牙裔成年人比非西班牙裔白人 (NHW) 成年人更低的消费和OBV使用. NHB的ED使用率较高;西班牙裔的住院率较低. 功能限制影响了跨种族/族群的OBV和住院模式.
结论:
- 针对性医疗干预对于高风险人群至关重要,特别是那些患有复杂慢性疾病的人群.
- 在获得和利用医疗保健方面,解决与种族/民族和功能限制相关的差异至关重要.
- 考虑到并发症,种族/种族和功能状况的个性化护理策略可以减轻健康负担.
相关概念视频
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Dimensions of Health and Illness
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


